Hepion Pharmaceuticals (HEPA) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free HEPA Stock Alerts $1.12 -0.02 (-1.76%) (As of 05/24/2024 03:41 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Hepion Pharmaceuticals Short Interest DataCurrent Short Interest63,900 sharesPrevious Short Interest64,000 sharesChange Vs. Previous Month-0.16%Dollar Volume Sold Short$87,223.50Short Interest Ratio0.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares5,470,000 sharesFloat Size5,390,000 sharesShort Percent of Float1.19%Today's Trading Volume43,600 sharesAverage Trading Volume65,851 sharesToday's Volume Vs. Average66% Short Selling Hepion Pharmaceuticals ? Sign up to receive the latest short interest report for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHEPA Short Interest Over TimeHEPA Days to Cover Over TimeHEPA Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself Hepion Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202463,900 shares $87,223.50 -0.2%1.2%0.9 $1.37 4/15/202464,000 shares $139,520.00 +1.9%1.2%0.8 $2.18 3/31/202462,800 shares $156,372.00 +11.0%1.5%0.8 $2.49 3/15/202456,600 shares $127,916.00 -19.6%1.3%0.7 $2.26 2/29/202470,400 shares $209,088.00 -11.0%1.6%0.8 $2.97 2/15/202479,100 shares $211,988.00 +18.2%1.9%0.9 $2.68 Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202466,900 shares $127,110.00 -17.7%1.6%0.9 $1.90 1/15/202481,300 shares $223,575.00 -18.0%1.9%1.2 $2.75 12/31/202399,200 shares $321,408.00 -18.5%2.3%1.5 $3.24 12/15/2023121,700 shares $484,366.00 -61.6%2.8%1.9 $3.98 11/30/2023317,200 shares $1.02 million -4.4%7.4%5.7 $3.22 11/15/2023331,700 shares $959,011.04 +15.0%7.8%6.8 $2.89 10/31/2023288,500 shares $1.35 million -22.8%6.9%8.8 $4.67 10/15/2023373,700 shares $1.72 million -11.4%9.9%12.3 $4.61 9/30/2023421,900 shares $2.11 million +10.5%11.2%15.7 $4.99 9/15/2023381,700 shares $2.00 million +24.9%10.1%13.3 $5.25 8/31/2023305,700 shares $2.28 million +3.1%8.0%8.9 $7.45 8/15/2023296,600 shares $2.07 million -8.9%7.7%0.8 $6.99 7/31/2023325,700 shares $2.59 million +2.4%8.6%0.9 $7.95 7/15/2023318,000 shares $3.18 million -1.8%8.4%0.9 $9.99 6/30/2023323,800 shares $3.40 million -11.1%8.5%0.9 $10.50 6/15/2023364,100 shares $4.21 million +52.9%9.6%1 $11.57 5/31/2023238,200 shares $2.29 million +237.4%6.3%0.7 $9.60 5/15/202370,600 shares $473,020.00 +105.8%1.9%0.2 $6.70 4/30/2023685,900 shares $477,043.45 +6.3%0.9%3.8 $0.70 4/15/2023645,100 shares $490,276.00 -7.7%0.9%2.6 $0.76 3/31/2023698,800 shares $542,618.20 -2.8%0.9%1 $0.78 3/15/2023719,000 shares $540,328.50 +0.3%0.9%1 $0.75 2/28/2023716,600 shares $625,950.10 -13.8%0.9%1 $0.87 2/15/2023831,100 shares $706,435.00 -8.3%1.1%1.1 $0.85 1/31/2023905,900 shares $661,125.82 -49.1%1.2%1.2 $0.73 1/15/20231,780,000 shares $1.65 million +221.0%2.3%2.5 $0.93 12/30/2022554,600 shares $166,546.38 +0.3%0.7%1.7 $0.30 12/15/2022553,100 shares $182,523.00 +3.2%0.7%2.6 $0.33 11/30/2022535,800 shares $195,674.16 -2.5%0.7%2.9 $0.37 11/15/2022549,700 shares $241,813.03 -5.4%0.7%3.2 $0.44 10/31/2022581,200 shares $309,489.00 -9.9%0.8%3.9 $0.53 10/15/2022645,200 shares $296,727.48 -6.6%0.9%4.7 $0.46 9/30/2022691,000 shares $349,093.20 -6.3%0.9%4.9 $0.51 9/15/2022737,500 shares $441,025.00 -9.5%1.0%5.1 $0.60Who are Nvidia’s New Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” 8/31/2022814,700 shares $556,195.69 -15.3%1.1%5.2 $0.68 8/15/2022961,600 shares $712,834.08 -12.6%1.3%5.9 $0.74 7/31/20221,100,000 shares $594,000.00 +21.6%1.5%5.6 $0.54 7/15/2022904,700 shares $544,086.58 -7.7%1.2%4.6 $0.60 6/30/2022980,300 shares $561,221.75 -7.5%1.3%4.9 $0.57 6/15/20221,060,000 shares $717,620.00 -7.0%1.4%4.6 $0.68 5/31/20221,140,000 shares $889,314.00 -7.3%1.5%4.8 $0.78 5/15/20221,230,000 shares $852,390.00 -14.6%1.6%4.1 $0.69 4/30/20221,440,000 shares $1.33 million -9.4%1.9%4.6 $0.93 4/15/20221,590,000 shares $1.67 million -7.0%2.1%4.3 $1.05 3/31/20221,710,000 shares $2.21 million +8.2%2.3%4.2 $1.29 3/15/20221,580,000 shares $1.69 million -0.6%2.1%3 $1.07 2/28/20221,590,000 shares $1.75 million -5.4%2.1%2.8 $1.10 2/15/20221,680,000 shares $1.71 million -10.2%2.2%2.7 $1.02 1/31/20221,870,000 shares $1.83 million +2.2%2.5%2.6 $0.98 1/15/20221,830,000 shares $2.12 million -6.2%2.4%2.4 $1.16 12/31/20211,950,000 shares $2.22 million +2.6%2.6%2.6 $1.14 12/15/20211,900,000 shares $2.30 million +15.2%2.5%2.4 $1.21 11/30/20211,650,000 shares $2.05 million -7.8%2.2%1.5 $1.24 11/15/20211,790,000 shares $2.63 million -1.1%2.4%1.5 $1.47 10/29/20211,810,000 shares $2.59 million -11.3%2.4%1.5 $1.43 10/15/20212,040,000 shares $3.10 million +17.9%2.7%1.6 $1.52 9/30/20211,730,000 shares $2.65 million -40.1%2.3%1.1 $1.53 9/15/20212,890,000 shares $4.60 million +61.5%3.8%1.7 $1.59 8/31/20211,790,000 shares $2.88 million -10.5%2.4%0.9 $1.61 8/13/20212,000,000 shares $2.94 million -14.5%2.6%1.1 $1.47 7/30/20212,340,000 shares $3.60 million -2.1%3.1%1.2 $1.54 7/15/20212,390,000 shares $3.80 million +64.8%3.1%1.1 $1.59 6/30/20211,450,000 shares $2.87 million -13.7%1.9%0.7 $1.98 6/15/20211,680,000 shares $3.70 million +27.3%2.2%0.8 $2.20 5/28/20211,320,000 shares $2.24 million +6.5%1.7%0.4 $1.70 5/14/20211,240,000 shares $1.93 million -32.6%N/A0.3 $1.56 4/30/20211,840,000 shares $3.28 million -20.7%N/A0.3 $1.78 4/15/20212,320,000 shares $4.08 million -22.9%N/A0.4 $1.76 3/31/20213,010,000 shares $5.36 million +57.6%N/A0.5 $1.78 3/15/20211,910,000 shares $4.66 million -26.5%N/A0.3 $2.44 2/26/20212,600,000 shares $5.10 million +273.3%N/A0.5 $1.96 2/12/2021696,500 shares $1.98 million +159.7%N/A0.1 $2.84 1/29/2021268,200 shares $549,810.00 -6.8%N/A0.1 $2.05 1/15/2021287,600 shares $672,984.00 -58.0%N/A0.1 $2.34 12/31/2020685,100 shares $1.61 million +236.7%N/A0.4 $2.35 12/15/2020203,500 shares $386,650.00 -43.4%N/A0.1 $1.90 11/30/2020359,500 shares $607,555.00 +9.7%N/A0.4 $1.69 11/15/2020327,600 shares $956,592.00 +51.3%N/A1.5 $2.92 10/30/2020216,600 shares $723,444.00 -39.7%N/A0.9 $3.34 10/15/2020359,400 shares $1.25 million -26.7%N/A0.9 $3.47 9/30/2020490,500 shares $1.53 million +4.1%N/A0.9 $3.11 9/15/2020471,000 shares $1.53 million -22.7%N/A0.3 $3.25 HEPA Short Interest - Frequently Asked Questions What is Hepion Pharmaceuticals' current short interest? Short interest is the volume of Hepion Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 63,900 shares of HEPA short. 1.19% of Hepion Pharmaceuticals' shares are currently sold short. Learn More on Hepion Pharmaceuticals' current short interest. What is a good short interest ratio for Hepion Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HEPA shares currently have a short interest ratio of 1.0. Learn More on Hepion Pharmaceuticals's short interest ratio. What is a good short interest percentage for Hepion Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.19% of Hepion Pharmaceuticals' floating shares are currently sold short. Is Hepion Pharmaceuticals' short interest increasing or decreasing? Hepion Pharmaceuticals saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 63,900 shares, a decrease of 0.2% from the previous total of 64,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Hepion Pharmaceuticals' float size? Hepion Pharmaceuticals currently has issued a total of 5,470,000 shares. Some of Hepion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hepion Pharmaceuticals currently has a public float of 5,390,000 shares. How does Hepion Pharmaceuticals' short interest compare to its competitors? 1.19% of Hepion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Hepion Pharmaceuticals: Enveric Biosciences, Inc. (1.07%), Ainos, Inc. (2.12%), Synaptogenix, Inc. (2.88%), Cadrenal Therapeutics, Inc. (0.80%), Soligenix, Inc. (6.22%), Pasithea Therapeutics Corp. (1.34%), Adial Pharmaceuticals, Inc. (4.42%), eFFECTOR Therapeutics, Inc. (3.12%), TFF Pharmaceuticals, Inc. (4.07%), Shuttle Pharmaceuticals Holdings, Inc. (0.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Hepion Pharmaceuticals stock? Short selling HEPA is an investing strategy that aims to generate trading profit from Hepion Pharmaceuticals as its price is falling. HEPA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hepion Pharmaceuticals? A short squeeze for Hepion Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HEPA, which in turn drives the price of the stock up even further. How often is Hepion Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HEPA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ENVB Short Interest Data AIMD Short Interest Data SNPX Short Interest Data CVKD Short Interest Data SNGX Short Interest Data KTTA Short Interest Data ADIL Short Interest Data EFTR Short Interest Data TFFP Short Interest Data SHPH Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HEPA) was last updated on 5/27/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeNew Options need New Trading StrategiesNetpicks$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyJust $9 for a Year of Winning Market InsightsBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.